Melatonin Agb Pharma (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus, the central clock that controls circadian rhythms. Activation of these receptors signals the body that it is night time, helping to synchronize internal biological rhythms and promote the onset of sleep.

The appropriate dose of Melatonin Agb Pharma is determined by the prescribing healthcare professional based on the individual’s age, condition, and response to therapy. Patients should follow the dose and schedule provided by their prescriber and not adjust the amount on their own.

Safety data for melatonin use in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting Melatonin Agb Pharma.

To order, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details and any required import documentation.

Unlike benzodiazepines or non‑benzodiazepine hypnotics, melatonin works by mimicking the body’s natural hormone rather than depressing the central nervous system. This generally results in a lower risk of dependence and fewer cognitive side effects, though efficacy may vary depending on the specific sleep disorder.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Melatonin Agb Pharma is taken orally, usually as a tablet or capsule, with water. It is commonly taken 30‑60 minutes before the desired bedtime, but the exact timing should follow the prescriber’s instructions.

Serious risks, though rare, include allergic reactions such as rash, itching, swelling, or difficulty breathing. Mood alterations such as depression or agitation have also been reported. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to melatonin, those taking certain medications that may interact severely (e.g., anticoagulants, immunosuppressants), and patients with uncontrolled severe hepatic or renal impairment should avoid using Melatonin Agb Pharma unless advised otherwise by a healthcare professional.